VITARINE's TRIAMTERENE/HYDROCHLOROTHIAZIDE WILL BE ONLY GENERIC VERSION OF MYLAN's MAXZIDE ON MARKET UNTIL APRIL 17; FIRM's ANDA APPROVED DEC. 8

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet